Home » Topics » BioWorld Science

BioWorld Science
RSS

Pivotal trial of thalidomide in AIDS patients completed

Oct. 18, 1996

Norvir now available in U.K.

Oct. 18, 1996

Shionogi begins clinical trials with novel reverse transcriptase inhibitor

Oct. 18, 1996

Retroviral zinc finger inhibitors as anti-HIV agents

Oct. 18, 1996

Glaxo Wellcome claims antiviral agents with RNA virus specificity

Oct. 18, 1996

RiboGene receives grant for antiviral compounds based on PKR

Oct. 18, 1996

Antimicrobial collaboration between Human Genome Sciences and Pharmacia & Upjohn

Oct. 18, 1996

Neuprex enters pivotal trials

Oct. 18, 1996

Bristol-Myers Squibb obtains rights to Kyorin antibiotic

Oct. 18, 1996

Proceedings report improved patient outcome with ADCON-L

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...